BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30079122)

  • 21. Multistaining Optimization for Epstein-Barr Virus-Encoded RNA In Situ Hybridization and Immunohistochemistry of Formalin-Fixed Paraffin-Embedded Tissues Using an Automated Immunostainer.
    Ko JN; Jung JK; Park YI; Shin HJ; Huh J; Back S; Kim YJ; Kim JH; Go H
    J Pathol Transl Med; 2019 Sep; 53(5):317-326. PubMed ID: 31455058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining fluorescence-based image segmentation and automated microfluidics for ultrafast cell-by-cell assessment of biomarkers for HER2-type breast carcinoma.
    Migliozzi D; Nguyen HT; Gijs MAM
    J Biomed Opt; 2018 Nov; 24(2):1-8. PubMed ID: 30484294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An integrated microfluidic system for rapid, automatic and high-throughput staining of clinical tissue samples for diagnosis of ovarian cancer.
    Huang SP; Chuang YJ; Lee WB; Tsai YC; Lin CN; Hsu KF; Lee GB
    Lab Chip; 2020 Mar; 20(6):1103-1109. PubMed ID: 32040102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis.
    Shi SR; Liu C; Taylor CR
    J Histochem Cytochem; 2007 Feb; 55(2):105-9. PubMed ID: 16982846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using immunofluorescent digital slide technology to quantify protein expression in archival paraffin-embedded tissue sections.
    Hashiguchi A; Hashimoto Y; Suzuki H; Sakamoto M
    Pathol Int; 2010 Nov; 60(11):720-5. PubMed ID: 20946521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.
    Park IH; Kwon Y; Ro JY; Lee KS; Ro J
    Breast Cancer Res Treat; 2010 Aug; 123(1):125-8. PubMed ID: 19916047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system.
    Laurinaviciene A; Plancoulaine B; Baltrusaityte I; Meskauskas R; Besusparis J; Lesciute-Krilaviciene D; Raudeliunas D; Iqbal Y; Herlin P; Laurinavicius A
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S10. PubMed ID: 25565007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
    Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
    Lim SJ; Cantillep A; Carpenter PM
    Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraffin-embedded Tissue Fragment Suspension (PETFS): A Novel Method for Quality Control Preparation in Immunohistochemistry.
    Ding W; Huang K; Lü B; Xu L; Liu J; Jiang C; Teng X; Ren X; Wang B
    Appl Immunohistochem Mol Morphol; 2017; 25(10):746-753. PubMed ID: 27153444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could quantitative real-time polymerase chain reaction assay serve as an alternative test method to evaluate human epidermal growth factor receptor 2 status of gastric carcinoma in the South Asian setting?
    Kannangara DKS; Lokuhetty MDS; Subasinghe D; Gunawardene YINS; Dassanayake RS
    Indian J Gastroenterol; 2019 Aug; 38(4):317-324. PubMed ID: 31401730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissue.
    Shi Y; Huang W; Tan Y; Jin X; Dua R; Penuel E; Mukherjee A; Sperinde J; Pannu H; Chenna A; DeFazio-Eli L; Pidaparthi S; Badal Y; Wallweber G; Chen L; Williams S; Tahir H; Larson J; Goodman L; Whitcomb J; Petropoulos C; Winslow J
    Diagn Mol Pathol; 2009 Mar; 18(1):11-21. PubMed ID: 19214113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Automated and Conventional IHC Visual Scoring Analysis for MHC Class I and Tapasin Expression in Cervical Carcinoma.
    Wanram S; Sombatwong J; Sakunpong A; Prasongdee P; Panomket P; Wongsena P; Limpaiboon T; Jearanaikoon P
    J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S67-75. PubMed ID: 26817241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardizing Immunohistochemistry: A New Reference Control for Detecting Staining Problems.
    Sompuram SR; Vani K; Tracey B; Kamstock DA; Bogen SA
    J Histochem Cytochem; 2015 Sep; 63(9):681-90. PubMed ID: 25940339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfluidic-Based Immunohistochemistry Combined With Next-Generation Sequencing on Diagnostic Tissue Sections for Detection of Tumoral BRAF V600E Mutation.
    Leblond AL; Rechsteiner M; Jones A; Brajkovic S; Dupouy D; Soltermann A
    Am J Clin Pathol; 2019 Jun; 152(1):59-73. PubMed ID: 31065676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study.
    Hicks DG; Buscaglia B; Goda H; McMahon L; Natori T; Turner B; Soukiazian A; Okada H; Nakano Y
    BMC Cancer; 2018 Dec; 18(1):1266. PubMed ID: 30563489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
    Jacobs TW; Prioleau JE; Stillman IE; Schnitt SJ
    J Natl Cancer Inst; 1996 Aug; 88(15):1054-9. PubMed ID: 8683636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A practical approach for the optimization of channel integrity in the sealing of shallow microfluidic devices made from cyclic olefin polymer.
    Ganser P; Baum C; Chargin D; Sauer-Budge AF; Sharon A
    Biomed Microdevices; 2018 Feb; 20(2):24. PubMed ID: 29478142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks.
    Ge X; Wang H; Zeng H; Jin X; Sujie A; Xu C; Liu Y; Huang J; Ji Y; Tan Y; Liu T; Hou Y; Qin J; Sun Y; Qin X
    Hum Pathol; 2015 Jun; 46(6):850-7. PubMed ID: 25863425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical basis of the 'magnification rule' for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer.
    Scheel AH; Penault-Llorca F; Hanna W; Baretton G; Middel P; Burchhardt J; Hofmann M; Jasani B; Rüschoff J
    Diagn Pathol; 2018 Mar; 13(1):19. PubMed ID: 29530054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.